Breathe Well Live Well
Condition: Asthma
Interventions: Drug: omalizumab; Biological: Rhinovirus (strain 16)
Sponsors: University of Virginia; National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting – verified March 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Fox News |
Experimental asthma drug hits a new target
Fox News An experimental drug that could help people with asthma or allergies works in a new way, by blocking the production of an inflammatory protein, according to a new study. The research is in its early stages and the drug, called quilizumab, has a long … |
View full post on asthma – Google News
|
Experimental Asthma Drug Hits a New Target
Yahoo News An experimental drug that could help people with asthma or allergies works in a new way, by blocking the production of an inflammatory protein, according to a new study. The research is in its early stages and the drug, called quilizumab, has a long … |
View full post on asthma – Google News
LiveScience.com |
Experimental Asthma Drug Hits a New Target
LiveScience.com An experimental drug that could help people with asthma or allergies works in a new way, by blocking the production of an inflammatory protein, according to a new study. The research is in its early stages and the drug, called quilizumab, has a long … |
View full post on asthma – Google News
|
AstraZeneca licenses experimental asthma drug
Philadelphia Business Journal (blog) AstraZeneca entered into an exclusive global licensing agreement Thursday for an experimental asthma drug being developed by Synairgen, a United Kingdom biopharmaceutical company. Under the terms of the deal, AstraZeneca (NYSE: AZN) will make an … |
View full post on asthma – Google News
|
VIDEO: Experimental inhaler targets small airways in asthma
The Oncology Report SAN DIEGO – An experimental inhalation system could help patients with asthma who are dependent on chronic oral corticosteroid therapy to reduce their doses of these steroids and potentially their side effects. A phase II/III study suggests the system … |
View full post on asthma – Google News
 CBS News |
Experimental Asthma Drug May Provide Major Relief–But For a Limited Group of …
TIME A promising new drug for treating asthma could not only reduce asthma symptoms but also improve lung function in patients, according to a new study. The results of the trial involving dupilumab, which is being developed by Regeneron Pharmaceuticals and … Experimental asthma drug helps untreatable patients in study New asthma drug promising in trials New Drug May Decrease Asthma Attacks By 87% |
View full post on asthma – Google News
CBS News |
Experimental asthma drug helps untreatable patients in study
CBS News Asthma suffers who aren't helped by existing medications may have reason to breathe a sigh of relief. An experimental drug called dupilumab was shown to reduce asthma attacks and helped boost lung function for people with moderate to severe asthma … New drug could reduce asthma attacks by 87 percent Experimental drug touted as potential game changer for asthma sufferers UPDATE 1-Regeneron, Sanofi asthma drug seen as potential game changer |
View full post on asthma – Google News
 Telegraph.co.uk |
Experimental Asthma Drug Halves Attacks
The Inquisitr The Telegraph reports the medicine is called mepolizumab and treats a rare form of the condition in which white blood cells called eosinophils cause lung airways to become inflamed. The new asthma drug is injected, and reduces the number of eosinophils … Glaxo's Experimental Drug Halves Asthma Attacks in Study Experimental Drug May Cut Severe Asthma Attacks: Study GSK drug halves attacks in hard-to-treat asthma |
View full post on asthma – Google News
|
Experimental Drug May Cut Severe Asthma Attacks: Study
iVillage Entertainment THURSDAY, Aug. 16 (HealthDay News) — An experimental drug known as mepolizumab may reduce outbreaks by almost 50 percent in people with a type of hard-to-treat asthma, an early study finds. About a third of people with severe asthma have what is … |
View full post on asthma – Google News